Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 20, 2026 16:00 ET | Source: Canon U.S.A., Inc.

Canon Ranked Seventh in U.S. Patent Ranking, now in the Top10 for 42 Years Running

MELVILLE, NY, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Canon U.S.A. Inc., a leader in digital imaging solutions, today announced that its parent company, Canon Inc., ranked seventh in the number of patents...
January 20, 2026 06:18 ET | Source: Nuclear Diamond Batteries, Inc.

Nuclear Diamond Batteries, Inc. Announces Nasdaq Reservation of Ticker Symbol “NDBI” in Connection with Planned Nasdaq Uplisting

Mesquite, NV , Jan. 20, 2026 (GLOBE NEWSWIRE) -- January 20, 2026, Mesquite, NV , (GLOBE NEWSWIRE) Nuclear Diamond Batteries, Inc. (the “Company”) today announced that Nasdaq has reserved the...
January 08, 2026 12:08 ET | Source: Equity Insider

The $170B Survival Race: Why Big Pharma is Snapping Up Late-Stage Cancer Tech

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, British Columbia, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Equity-Insider.com News Commentary – Biopharma M&A is entering a fever pitch, with...
December 31, 2025 07:00 ET | Source: Nutriband Inc.

Nutriband CEO Publishes Letter to Shareholders

Nutriband New Year Letter to Shareholders
December 29, 2025 09:00 ET | Source: Nutriband Inc.

Nutriband Inc. Signs Agreement to Sell Majority Stake of Subsidiary Pocono Pharmaceutical for $5M USD to EarthVision Bio

Nutriband signs agreement to sell majority stake in Pocono for $5M
December 29, 2025 06:18 ET | Source: Nuclear Diamond Batteries, Inc.

Nuclear Diamond Batteries, Inc. (OTCID: WEDG) Announces Completion of Corporate Name Change Following FINRA Processing

Mesquite, NV , Dec. 29, 2025 (GLOBE NEWSWIRE) -- Mesquite, NV December 29, 2025 GlobeNewsWire— Nuclear Diamond Batteries, Inc. (OTCID: WEDG) (“the Company”) today confirms that FINRA has completed...
December 17, 2025 09:15 ET | Source: Longeveron

Longeveron Granted U.S. Patent for Method of Treating Female Sexual Dysfunction Using its Proprietary Stem Cell Therapy

Longeveron granted US patent for method of treating female sexual dysfunction using its proprietary stem cell therapy laromestrocel.
November 12, 2025 09:05 ET | Source: Longeveron

Longeveron Granted U.S. Patent for Method of Treating Aging-related Frailty in Patients with Inflammaging Using its Proprietary Stem Cell Therapy

Longeveron issued US patent for method of treating aging-related frailty in patients with inflammaging using its proprietary stem cell therapy.
October 28, 2025 11:05 ET | Source: Nutriband Inc.

REPEAT — Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch

Positive FDA meeting
October 28, 2025 07:00 ET | Source: Nutriband Inc.

Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch

Positive FDA meeting